JPS63101334A - 持続放出型医薬組成物 - Google Patents

持続放出型医薬組成物

Info

Publication number
JPS63101334A
JPS63101334A JP62256149A JP25614987A JPS63101334A JP S63101334 A JPS63101334 A JP S63101334A JP 62256149 A JP62256149 A JP 62256149A JP 25614987 A JP25614987 A JP 25614987A JP S63101334 A JPS63101334 A JP S63101334A
Authority
JP
Japan
Prior art keywords
composition according
hydroxypropyl methylcellulose
microcrystalline cellulose
acetylsalicylic acid
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62256149A
Other languages
English (en)
Japanese (ja)
Inventor
ヘンリー・シー・ガン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS63101334A publication Critical patent/JPS63101334A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP62256149A 1986-10-09 1987-10-08 持続放出型医薬組成物 Pending JPS63101334A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
GB8624213 1987-10-09

Publications (1)

Publication Number Publication Date
JPS63101334A true JPS63101334A (ja) 1988-05-06

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62256149A Pending JPS63101334A (ja) 1986-10-09 1987-10-08 持続放出型医薬組成物

Country Status (24)

Country Link
JP (1) JPS63101334A (enrdf_load_stackoverflow)
KR (1) KR880004801A (enrdf_load_stackoverflow)
AU (1) AU7942087A (enrdf_load_stackoverflow)
BE (1) BE1000732A5 (enrdf_load_stackoverflow)
CA (1) CA1332809C (enrdf_load_stackoverflow)
CH (1) CH675831A5 (enrdf_load_stackoverflow)
DE (1) DE3733540A1 (enrdf_load_stackoverflow)
DK (1) DK527487A (enrdf_load_stackoverflow)
ES (1) ES2014518A6 (enrdf_load_stackoverflow)
FI (1) FI874414A7 (enrdf_load_stackoverflow)
FR (1) FR2604902B1 (enrdf_load_stackoverflow)
GB (2) GB8624213D0 (enrdf_load_stackoverflow)
GR (1) GR871550B (enrdf_load_stackoverflow)
HU (1) HU201875B (enrdf_load_stackoverflow)
IL (1) IL84104A0 (enrdf_load_stackoverflow)
IT (1) IT1221493B (enrdf_load_stackoverflow)
LU (1) LU87009A1 (enrdf_load_stackoverflow)
NL (1) NL8702294A (enrdf_load_stackoverflow)
NO (1) NO874200L (enrdf_load_stackoverflow)
NZ (1) NZ222083A (enrdf_load_stackoverflow)
PH (1) PH24227A (enrdf_load_stackoverflow)
PT (1) PT85880B (enrdf_load_stackoverflow)
SE (1) SE8703889L (enrdf_load_stackoverflow)
ZA (1) ZA877617B (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP2002541090A (ja) * 1999-03-31 2002-12-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 制御放出製剤中の前糊化澱粉
JP4814885B2 (ja) * 2004-09-09 2011-11-16 サイコファルマ，エッセ．エ．デ セ．ウヴェ． ヒドララジン持続放出用医薬組成物および該組成物を含む癌治療薬

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP2002541090A (ja) * 1999-03-31 2002-12-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 制御放出製剤中の前糊化澱粉
JP4814885B2 (ja) * 2004-09-09 2011-11-16 サイコファルマ，エッセ．エ．デ セ．ウヴェ． ヒドララジン持続放出用医薬組成物および該組成物を含む癌治療薬

Also Published As

Publication number Publication date
BE1000732A5 (fr) 1989-03-21
HUT52958A (en) 1990-09-28
PT85880B (pt) 1990-07-31
DK527487D0 (da) 1987-10-08
PH24227A (en) 1990-05-04
FI874414L (fi) 1988-04-10
ZA877617B (en) 1989-05-30
NL8702294A (nl) 1988-05-02
NO874200L (no) 1988-04-11
NZ222083A (en) 1991-05-28
IT1221493B (it) 1990-07-06
IT8748469A0 (it) 1987-10-08
IL84104A0 (en) 1988-03-31
FR2604902A1 (fr) 1988-04-15
PT85880A (en) 1987-11-01
HU201875B (en) 1991-01-28
CH675831A5 (enrdf_load_stackoverflow) 1990-11-15
FR2604902B1 (fr) 1991-04-26
LU87009A1 (fr) 1988-05-03
KR880004801A (ko) 1988-06-27
GB8624213D0 (en) 1986-11-12
AU7942087A (en) 1988-04-14
NO874200D0 (no) 1987-10-07
ES2014518A6 (es) 1990-07-16
GB2195893B (en) 1991-05-08
FI874414A7 (fi) 1988-04-10
GR871550B (en) 1988-02-15
GB8723515D0 (en) 1987-11-11
SE8703889D0 (sv) 1987-10-08
CA1332809C (en) 1994-11-01
DK527487A (da) 1988-04-10
GB2195893A (en) 1988-04-20
DE3733540A1 (de) 1988-04-14
SE8703889L (sv) 1988-04-10
FI874414A0 (fi) 1987-10-07

Similar Documents

Publication Publication Date Title
AU2003275855B2 (en) Sustained-release tramadol formulations with 24-hour efficacy
KR100283709B1 (ko) 안정한 서방성 경구 투여 조성물
AU2013274003B2 (en) Compositions and methods for transmucosal absorption
TWI314866B (en) Guaifenesin sustained release formulation and tablets
US5451409A (en) Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
AU2001260212C1 (en) Composition
PT1351668E (pt) Formas de dosagem farmacêutica de libertação sustida com perfis de dissolução dependentes de ph minimizado
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
JPH03200724A (ja) 二重作用錠剤
HUP0001382A2 (hu) Eritromicinszármazékokat tartalmazó, ezek késleltetett felszabadulását biztosító készítmények
JPH0669965B2 (ja) 固体持続放出医薬製剤
TW508242B (en) Pharmaceutical composition comprising paracetamol
KR101464771B1 (ko) 페닐에프린의 지속 방출용 약제학적 조성물
AU2009276664B2 (en) Novel method
JP2002326927A (ja) 塩酸メトホルミン含有速放性錠剤
Mohapatra et al. Formulation, development and evaluation of patient friendly dosage forms of metformin, Part-I: Orally disintegrating tablets
JPS63101334A (ja) 持続放出型医薬組成物
US7838032B2 (en) Sustained release of guaifenesin
TWI326212B (en) Non-effervescent dosage form intended to be swallowed directly
US7985420B2 (en) Sustained release of guaifenesin combination drugs
CN111991362A (zh) 一种替格瑞洛缓释片及其制备方法
AU2014295099A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
Kumar et al. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
JP2521463B2 (ja) 塩酸ジラゼプ持効性錠剤